Retinal anti-VEGF regimens requiring frequent monitoring generate indirect patient costs that often outweigh direct expenses ...

ScribeHealth, a leading healthcare technology company specializing in ambient AI and mobile-first documentation solutions, announced its selection as a Preferred Partner by athenahealth, a leading ...

Sutacimig Phase 2 long-term extension (LTE) data show sustained bleed reduction and manageable safety and tolerability; Phase 3 initiation planned 2H 2026 Preclinical data for sutacimig in Factor VII ...

Switchboard, MD today announced it has joined athenahealth's Partner Community as a Solution Partner. Its solution is now ...

Alexandria Real Estate has quietly set a big shift in motion at 311 Arsenal Street in Watertown, filing permits to overhaul part of the former athenahealth headquarters so three biotech tenants can ...